Bivalent EABR mRNA boosters broaden neutralizing responses to Omicron subvariants by promoting diverse receptor-binding domain epitope targeting, although antibody responses remain partially shaped by ...
Experimental infections, where a pathogen is introduced into the host body to see its effects in action, are considered the ...
Following the rise in Mpox cases, particularly in countries where the disease had not traditionally been observed, the World ...
The FDA has also granted bepirovirsen breakthrough therapy designation, building on a fast track designation from the agency in February 2024.